Microba Life Sciences (MAP) Short Interest
Microba Life Sciences (ASX:MAP) had 0.10% of shares reported as short positions as of 15 June 2026, representing 700,000 shares. Microba Life Sciences operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Microba Life Sciences
Microba Life Sciences is a pioneering company in the health care sector, specializing in advanced microbiome analysis technology. Their innovative approach provides deep insights into gut health, enabling precision diagnostics and personalized treatment plans. With a strong focus on scientific rigor and evidence-based solutions, Microba is positioned as a leader in microbiome research and diagnostics.
Short position
Microba Life Sciences (ASX:MAP) has 0.10% of its shares on issue reported as short positions as of 15 June 2026, or about 700,000 shares. Over the past 30 days that figure has risen 0.19 percentage points, and over 90 days it has risen 0.19 percentage points. Its highest recorded short interest was 0.81% in June 2025. MAP is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4MAP intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Microba Life Sciences
Latest MAP news
All newsAbout
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss MAP
Start a research thread or post the first pulse update